Last Price (EGP) | 43.08 |
Prev. Close | 43.580 |
Day Range | 43.04 - 44.20 |
52WK range | |
Turnover (M EGP) | 3.14 |
Volume (M) | 0.07 |
Number of Trades | 207 |
Market Cap (M EGP) | 3,639.55 |
Change in Market Cap (M EGP) | |
VWAP (EGP) | 43.08 |
EPS (TTM) | -- |
EX-Dividend Date | |
Dividend | |
Dividend Yield (%) | |
Beta | |
30D Avg Volume | |
30D Avg Turnover(M EGP) | |
Outstanding Shares | |
Free Float Shares | |
Free Float % |
Highest Market Cap | |
Date of Highest Mkt. Cap | |
Lowest Market Cap | |
Date of Lowest Mkt. Cap |
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) posted consolidated net profits amounting to EGP 92.55 million in the first half (H1)...
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) turned to a consolidated net loss of EGP 8.98 million in the first quarter (Q1) of 2024,...
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) plans to disburse cash dividends valued at EGP 0.75 per share for 2023, according to a bourse...
Cairo – Mubasher: GlaxoSmithKline’s (GSK Egypt) consolidated net profit plunged to EGP 60.47 million in 2023 from EGP 735.39 million a...
Cairo – Mubasher: The consolidated net profits after tax of GlaxoSmithKline (GSK Egypt) plummeted to EGP 46.72 million in the first nine...